A preliminary study on the synthetic lethal effect of berberine and olaparib on pancreatic cancer cells and its mechanism
Open Access
- 27 January 2021
- journal article
- research article
- Published by EDP Sciences in E3S Web of Conferences
- Vol. 233, 02023
- https://doi.org/10.1051/e3sconf/202123302023
Abstract
Pancreatic cancer is a kind of malignant tumor with high mortality rate. Early operation and late chemoradiotherapy are the treatment criteria, but the prognosis is still poor. Berberine, an alkaloid compound present in many herbal plants, is capable of inducing oxidative DNA damage and downregulating homologous recombination repair (HRR) in cancer cells. Poly (ADP ribose) polymerase-1 (PARP-1) is a sensor of DNA damage with key roles in DNA repair. In this study, we demonstrated that berberine and PARP inhibitor olaparib have a synthetic lethal effect on pancreatic cancer cells. The expression level of RAD51 were reduced by berberine. Correspondingly, PARP became hyperactivated in response to berberine treatment. When berberine is combined with olaparib, the expression of Rad51 and Parp are inhibited. The combination of berberine and olaparib synergistically inhibit cell activity and induce cell apoptosis. In addition, the synergistic effect of berberine and olaparib can be reversed by apoptosis inhibitor and necrosis inhibitor. Together, the results indicate that berberine combined with olaparib have a synthetic lethal effect on pancreatic cancer cells.This publication has 10 references indexed in Scilit:
- First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapyWorld Journal of Clinical Cases, 2020
- Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibitionCell Death & Disease, 2017
- PARP inhibitor combination therapyCritical Reviews in Oncology/Hematology, 2016
- Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888Translational Oncology, 2014
- Effects of Berberine in the Gastrointestinal Tract — A Review of Actions and Therapeutic ImplicationsThe American Journal of Chinese Medicine, 2014
- Radiosensitization effects of berberine on human breast cancer cellsInternational Journal of Molecular Medicine, 2012
- Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51PLOS ONE, 2011
- Oral Poly(ADP-Ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes with Oxaliplatin against Pancreatic Cancer, Preventing Acute NeurotoxicityClinical Cancer Research, 2009
- Targeting Poly(ADP-Ribose) Polymerase: A Two-Armed Strategy for Cancer TherapyClinical Cancer Research, 2007
- Combination therapy of poly (ADP‐ribose) polymerase inhibitor 3‐aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cellsJournal of Gastroenterology and Hepatology, 2007